These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 315974)

  • 21. An improved method for producing an antiserum against T-lymphocytes of the mouse.
    Eckert R
    J Immunol Methods; 1982; 51(1):45-8. PubMed ID: 6125543
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of mitotic thymus-derived lymphocytes by their sensitivity to the cytotoxic effects of anti-theta serum.
    Kerbel RS; Elliott EV; Wallis VJ
    Cell Immunol; 1974 Mar; 11(1-3):146-61. PubMed ID: 4616761
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigenic differences between spleen-seeking and lymph node-seeking thymus cells.
    Schlesinger M; Shlomai-Korzash Z; Israèl E
    Eur J Immunol; 1973 Jun; 3(6):335-9. PubMed ID: 4543317
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies specific for the theta- and Ly-alloantigens in various rabbit antisera.
    Rabinowitz R; Cohen A; Laskov R; Schlesinger M
    J Immunol; 1974 Feb; 112(2):683-92. PubMed ID: 4405954
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of B-immunocytes by a T-cell factor produced in mixed leukocyte cultures.
    Friedman H
    Ann N Y Acad Sci; 1975 Feb; 249():264-77. PubMed ID: 124153
    [No Abstract]   [Full Text] [Related]  

  • 27. Cross species immunosuppressive effects of antilymphocyte serum in mice and rats.
    Motoji T; Chiba C
    Transplantation; 1972 Nov; 14(5):536-40. PubMed ID: 4563193
    [No Abstract]   [Full Text] [Related]  

  • 28. Ly-15: a new murine lymphocyte alloantigenic locus.
    Potter TA; Hogarth PM; McKenzie IF
    Transplantation; 1981 May; 31(5):339-42. PubMed ID: 6785912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential lysis of undifferentiated thymocytes by natural thymocytotoxic antibodies from New Zealand black mice.
    Huston DP; Raveche ES; Steinberg AD
    J Immunol; 1980 Apr; 124(4):1635-41. PubMed ID: 6988504
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequential analysis of the virus-immune responder characteristics of thymocytes from F1 leads to parent radiation chimeras.
    Korngold R; Doherty PC
    Thymus; 1982 May; 4(3):119-33. PubMed ID: 6981232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of xenoantisera on T-lymphocyte functions in the absence of complement.
    Rabinowitz R; Laskov R; Schlesinger M
    Adv Exp Med Biol; 1979; 121B():247-60. PubMed ID: 161848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.
    Marshak-Rothstein A; Fink P; Gridley T; Raulet DH; Bevan MJ; Gefter ML
    J Immunol; 1979 Jun; 122(6):2491-7. PubMed ID: 87465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivity of steroid-resistant neonatal thymocytes.
    Cohen PL; Mosier DE
    Nature; 1974 Sep; 251(5472):233-4. PubMed ID: 4138862
    [No Abstract]   [Full Text] [Related]  

  • 34. Soluble factors containing Thy-1 antigen shed from lymphoblastoid cells modulate in vitro plaque-forming cell response.
    Freimuth WW; Miller HC; Esselman WJ
    J Immunol; 1979 Jul; 123(1):201-8. PubMed ID: 376740
    [No Abstract]   [Full Text] [Related]  

  • 35. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens.
    Cerottini JC; MacDonald HR
    J Immunol; 1981 Feb; 126(2):490-6. PubMed ID: 6450245
    [No Abstract]   [Full Text] [Related]  

  • 36. H-2-nonrestricted cytotoxic responses to an antigen encoded telomeric to H-2D.
    Kastner DL; Rich RR
    J Immunol; 1979 Jan; 122(1):196-201. PubMed ID: 84017
    [No Abstract]   [Full Text] [Related]  

  • 37. The Ir-Thy-1 concept: facts and interpretation.
    Zaleski MB; Reichner JS
    Surv Immunol Res; 1982; 1(1):76-84. PubMed ID: 6138828
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune responses in vitro. VII. Loss of susceptibility of functional theta-bearing cells to cytotoxic action of anti-theta serum and complement in vitro.
    Pierce CW
    Cell Immunol; 1973 Dec; 9(3):465-73. PubMed ID: 4586158
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of responding cells in oxidative mitogen stimulation. I. Ia+ cells and Ly-1+2+ cells are required for the proliferative response.
    Phillips ML; Wettstein PJ; O'Brien RL; Parker JW; Frelinger JA
    J Immunol; 1980 Jun; 124(6):2693-9. PubMed ID: 6246169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.